KANAMYCIN RESISTANT STAPHYLOCOCCUS MUTANT REQUIRING HEME FOR GROWTH

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis

Introduction: The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gov...

Growth Responses of a Sulfonamide-requiring Mutant Strain of Neurospora.

Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.

A ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus (F145) contained no mutations within gyrA, gyrB, grlA, and grlB or within norA or its promoter region. MICs and accumulation studies suggest the role of a novel multidrug efflux pump.

audiological evaluation of patients taking kanamycin for multidrug resistant tuberculosis

introduction: the incidence of multidrug resistant tuberculosis is increasing in developing countries. aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. this study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for multidrug resistant tuberculosis (mdr-tb), kanamycin, at a gov...

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis

INTRODUCTION The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gove...